D M Gibo

Author PubWeight™ 14.01^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.	Clin Cancer Res	1999	1.84
2	Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen.	Mol Med	2000	1.41
3	Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.	Oncogene	2008	1.41
4	Novel anti-brain tumor cytotoxins specific for cancer cells.	Nat Biotechnol	1998	1.28
5	Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation.	Exp Cell Res	1998	1.24
6	Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.	J Neurooncol	2000	1.08
7	Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme.	Int J Oncol	1999	0.99
8	VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme.	Mol Med	2001	0.95
9	Reversion of uroepithelial cell tumorigenesis by the ectopic expression of human wnt-5a.	Cell Growth Differ	1997	0.84
10	Adult and developing human cerebella exhibit different profiles of opioid binding sites.	Brain Res	1990	0.81
11	Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13.	Int J Cancer	1998	0.81
12	Zeta (zeta), a growth-related opioid receptor in developing rat cerebellum: identification and characterization.	Brain Res	1991	0.81
13	Ontogeny of zeta (zeta), the opioid growth factor receptor, in the rat brain.	Brain Res	1992	0.77